BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 282 filers reported holding BLUEBIRD BIO INC in Q4 2019. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,064 | -40.2% | 265 | 0.0% | 0.00% | – |
| Q2 2021 | $8,475 | +6.1% | 265 | 0.0% | 0.00% | – |
| Q1 2021 | $7,990 | -30.3% | 265 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $11,467 | -19.8% | 265 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $14,297 | +260.3% | 265 | +307.7% | 0.00% | – |
| Q2 2020 | $3,968 | +32.8% | 65 | 0.0% | 0.00% | – |
| Q1 2020 | $2,987 | -47.6% | 65 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $5,704 | -4.4% | 65 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $5,968 | -27.8% | 65 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $8,268 | -19.1% | 65 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $10,226 | +58.6% | 65 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $6,448 | -32.1% | 65 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $9,490 | -7.0% | 65 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $10,202 | -8.1% | 65 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $11,099 | – | 65 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 4,282,827 | $13,019,794 | 1.84% |
| Birchview Capital, LP | 455,200 | $1,383,808 | 1.18% |
| PFM Health Sciences, LP | 6,040,934 | $18,364,439 | 0.86% |
| Lion Point Capital, LP | 531,256 | $1,615,018 | 0.72% |
| Endurant Capital Management LP | 251,785 | $765,426 | 0.69% |
| Bleichroeder LP | 900,000 | $2,736,000 | 0.67% |
| Connacht Asset Management LP | 31,634 | $96,167 | 0.57% |
| Granahan Investment Management | 5,137,778 | $15,618,845 | 0.56% |
| Frazier Life Sciences Management, L.P. | 1,709,907 | $5,198,117 | 0.34% |
| Contrarius Investment Management Ltd | 1,308,002 | $3,976 | 0.22% |